As of 2024-12-15, the Relative Valuation of Chemours Co (CC) is 8.43 USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.04 USD, the upside of Chemours Co based on Relative Valuation is -55.7%.
The range of the Relative Valuation is 6.69 - 9.98 USD.
| Range | Selected | |
| Trailing P/E multiples | 16.4x - 21.3x | 19.2x |
| Forward P/E multiples | 14.5x - 21.6x | 17.4x |
| Fair Price | 6.69 - 9.98 | 8.43 |
| Upside | -64.9% - -47.6% | -55.7% |
| Date | P/E |
| 2024-12-13 | 41.23 |
| 2024-12-12 | 42.01 |
| 2024-12-11 | 42.05 |
| 2024-12-10 | 45.84 |
| 2024-12-09 | 47.03 |
| 2024-12-06 | 45.47 |
| 2024-12-05 | 45.69 |
| 2024-12-04 | 46.08 |
| 2024-12-03 | 46.84 |
| 2024-12-02 | 46.88 |
| 2024-11-29 | 47.07 |
| 2024-11-27 | 47.25 |
| 2024-11-26 | 47.46 |
| 2024-11-25 | 47.51 |
| 2024-11-22 | 46.62 |
| 2024-11-21 | 45.04 |
| 2024-11-20 | 41.68 |
| 2024-11-19 | 40.82 |
| 2024-11-18 | 41.25 |
| 2024-11-15 | 40.90 |
| 2024-11-14 | 41.83 |
| 2024-11-13 | 41.49 |
| 2024-11-12 | 41.79 |
| 2024-11-11 | 42.90 |
| 2024-11-08 | 42.85 |
| 2024-11-07 | 44.28 |
| 2024-11-06 | 44.87 |
| 2024-11-05 | 43.05 |
| 2024-11-04 | 44.56 |
| 2024-11-01 | 38.59 |
| 2024-10-31 | 39.32 |
| 2024-10-30 | 39.65 |
| 2024-10-29 | 39.60 |
| 2024-10-28 | 40.02 |
| 2024-10-25 | 39.67 |
| 2024-10-24 | 40.28 |
| 2024-10-23 | 39.67 |
| 2024-10-22 | 40.47 |
| 2024-10-21 | 40.86 |
| 2024-10-18 | 42.55 |
| 2024-10-17 | 42.79 |
| 2024-10-16 | 43.00 |
| 2024-10-15 | 42.25 |
| 2024-10-14 | 43.22 |
| 2024-10-11 | 44.13 |
| 2024-10-10 | 42.83 |
| 2024-10-09 | 42.57 |
| 2024-10-08 | 42.31 |
| 2024-10-07 | 43.46 |
| 2024-10-04 | 42.38 |